347 results found

2026 is shaping up to be a pivotal year for health care reimbursement. From major CMS payment rules to evolving disclosure requirements, AI scrutiny, and mounting pressure on providers across the care continuum...

This month, Governor Newsom signed AB 1415 and SB 351 into law, two bills that will enhance the requirements on investments by private equity groups...

Examiner interviews are a powerful but underutilized tool in patent prosecution. Last year, a whopping 75% of patent applications concluded without a single interview in their file history.

CBP has informally outlined its position on how importers should calculate Section 232 duties for derivative goods made of steel, aluminum and copper.

AI may be both the most "powerful capability of our time" and the "most powerful weapon of our time." That's according to Jen Easterly, Director of the Cybersecurity and Infrastructure Security Agency...

On June 27, 2023, the U.S. Department of Health and Human Services ("HHS"), Office of Inspector General ("OIG") posted on its website a final rule implementing its civil money penalty ("CMPs")...

California's Office of Health Care Affordability ("OHCA") published updated draft regulations implementing SB 184's pre-transaction notice requirements.

Reliance on Physician Orders: Clinical laboratories may generally rely on physician orders to establish medical necessity and are not required to independently reassess clinical judgment.

On Tuesday, November 28, 2023, California's Office of Health Care Affordability ("OHCA") published its latest version of the proposed regulations requiring advanced notice of certain...

As part of Polsinelli's COVID-19 guidance, below we summarize three commonly asked questions regarding COVID-19 and obligations under CCPA and GDPR.

The California Privacy Protection Agency (CPPA) Board met on November 8th and voted to adopt new regulations for data broker registration requirements.

The Financial Crimes Enforcement Network ("FinCEN") recently published updates to its list of Frequently Asked Questions ("FAQs") to assist entities in complying...

CMS and DOJ activity related to the Stark Law has been notably quiet in recent years, with no material rule updates since 2023 and limited enforcement actions.

In legislation enacted on Feb. 3, 2026, Congress reauthorized the rare pediatric disease priority review voucher program, clarified the scope of orphan drug exclusivity...

On December 18, the Office of Inspector General (OIG) published Advisory Opinion No. 25-11, which provides one of the most detailed OIG articulations to date of how the Anti-Kickback Statute (AKS) and the Discount Safe Harbor apply to a variety of discount and rebate arrangements.

Product designs often serve as the cornerstone of a brand's identity, evoking instant recognition and loyalty among consumers.

The Blockchain Bi-Weekly presented by the Polsinelli Blockchain+ team is a rundown of some of the key stories in the Web3, blockchain and crypto ecosystems curated by our attorneys...